Search Results

Filter
  • 1-10 of  130 results for ""Oxidopamine""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The Absence of Gastrointestinal Redox Dyshomeostasis in the Brain-First Rat Model of Parkinson's Disease Induced by Bilateral Intrastriatal 6-Hydroxydopamine.

  • Authors : Homolak J; Department of Pharmacology & Croatian Institute for Brain Research, University of Zagreb School of Medicine, Salata 11, 10 000, Zagreb, Croatia. .; Interfaculty Institute of Microbiology and Infection Medicine & Cluster of Excellence 'Controlling Microbes to Fight Infections,', University of Tübingen, Tübingen, Germany. .

Subjects: Oxidopamine*/Oxidopamine*/Oxidopamine*/pharmacology ; Oxidation-Reduction*/Oxidation-Reduction*/Oxidation-Reduction*/drug effects ; Rats, Wistar*

  • Source: Molecular neurobiology [Mol Neurobiol] 2024 Aug; Vol. 61 (8), pp. 5481-5493. Date of Electronic Publication: 2024 Jan 10.Publisher: Humana Press Country of Publication: United States NLM ID: 8900963 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Generation of Mitochondrial Toxin Rodent Models of Parkinson's Disease Using 6-OHDA , MPTP , and Rotenone.

  • Authors : Maegawa H; Department of Dental Anesthesia, Osaka University Graduate School of Dentistry, Osaka, Japan. .; Niwa H

Subjects: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/*pharmacology ; Mitochondria/Mitochondria/Mitochondria/*drug effects ; Neurotoxins/Neurotoxins/Neurotoxins/*pharmacology

  • Source: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2021; Vol. 2322, pp. 95-110.Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Anthraquinone from Edible Fungi Pleurotus ostreatus Protects Human SH-SY5Y Neuroblastoma Cells Against 6-Hydroxydopamine-Induced Cell Death-Preclinical Validation of Gene Knockout Possibilities of PARK7, PINK1, and SNCA1 Using CRISPR SpCas9.

  • Authors : J B; Molecular Diagnostics and Bacterial Pathogenomics Research Laboratory, Department of Biotechnology, Bannari Amman Institute of Technology, Sathyamangalam, 638401, India.; Das A

Subjects: Cell Death/Cell Death/Cell Death/*drug effects ; Neuroblastoma/Neuroblastoma/Neuroblastoma/*metabolism ; Oxidopamine/Oxidopamine/Oxidopamine/*adverse effects

  • Source: Applied biochemistry and biotechnology [Appl Biochem Biotechnol] 2020 Jun; Vol. 191 (2), pp. 555-566. Date of Electronic Publication: 2019 Dec 09.Publisher: Humana Press Country of Publication: United States NLM ID: 8208561 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Lipid Analysis of the 6-Hydroxydopamine-Treated SH-SY5Y Cell Model for Parkinson's Disease.

  • Authors : Xicoy H; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Geert Grooteplein Zuid 26-28, 6525 GA, Nijmegen, The Netherlands.; Department of Molecular Animal Physiology, Faculty of Science, Donders Institute for Brain, Cognition and Behaviour, Donders Centre for Neuroscience, Geert Grooteplein Zuid 26-28, 6525 GA, Nijmegen, The Netherlands.

Subjects: Models, Biological*; Lipids/Lipids/Lipids/*analysis ; Oxidopamine/Oxidopamine/Oxidopamine/*toxicity

  • Source: Molecular neurobiology [Mol Neurobiol] 2020 Feb; Vol. 57 (2), pp. 848-859. Date of Electronic Publication: 2019 Sep 06.Publisher: Humana Press Country of Publication: United States NLM ID: 8900963 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Studying newt brain regeneration following subtype specific neuronal ablation.

  • Authors : Kirkham M; Department of Cell and Molecular Biology, Karolinska Institutet, Berzelius väg 35, Stockholm, 171 77, Sweden, .; Joven A

Subjects: Regeneration*; Brain/Brain/Brain/*cytology ; Brain/Brain/Brain/*physiology

  • Source: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2015; Vol. 1290, pp. 91-9.Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Astrocyte-Like Cells Differentiated from Dental Pulp Stem Cells Protect Dopaminergic Neurons Against 6-Hydroxydopamine Toxicity.

  • Authors : Ganapathy K; Department of Biophysics, National Institute of Mental Health and Neurosciences, P.B. No - 2900, Hosur Road, Bengaluru, Karnataka, 560029, India.; School of Regenerative Medicine, Manipal University, Bengaluru, Karnataka, 560065, India.

Subjects: Cell Differentiation*/Cell Differentiation*/Cell Differentiation*/drug effects; Astrocytes/Astrocytes/Astrocytes/*cytology ; Dental Pulp/Dental Pulp/Dental Pulp/*cytology

  • Source: Molecular neurobiology [Mol Neurobiol] 2019 Jun; Vol. 56 (6), pp. 4395-4413. Date of Electronic Publication: 2018 Oct 16.Publisher: Humana Press Country of Publication: United States NLM ID: 8900963 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Global microRNA expression profiling reveals differential expression of target genes in 6-hydroxydopamine-injured MN9D cells.

  • Authors : Li L; Department of Human Anatomy and Neurobiology, Xuzhou Medical College, Tongshan Road 209#, Xuzhou, 221009, China.; Chen HZ

Subjects: Gene Expression Regulation/Gene Expression Regulation/Gene Expression Regulation/*drug effects ; MicroRNAs/MicroRNAs/MicroRNAs/*genetics ; Neurotoxins/Neurotoxins/Neurotoxins/*toxicity

  • Source: Neuromolecular medicine [Neuromolecular Med] 2013 Sep; Vol. 15 (3), pp. 593-604. Date of Electronic Publication: 2013 Jul 12.Publisher: Humana Press Country of Publication: United States NLM ID: 101135365 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

A 6-hydroxydopamine in vivo model of Parkinson's disease.

  • Authors : Mercanti G; Department of Pharmacology and Anesthesiology, University of Padova, Padova, Italy. ; Bazzu G

Subjects: Disease Models, Animal*; Dopaminergic Neurons/Dopaminergic Neurons/Dopaminergic Neurons/*drug effects ; Oxidopamine/Oxidopamine/Oxidopamine/*toxicity

  • Source: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2012; Vol. 846, pp. 355-64.Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

ADHD animal model characterization: transcriptomics and proteomics analyses.

  • Authors : Masuo Y; Laboratory of Neuroscience, Department of Biology, Toho University, Funabashi, Chiba, Japan. ; Shibato J

Subjects: Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/*pathology ; Methamphetamine/Methamphetamine/Methamphetamine/*pharmacology ; Oxidopamine/Oxidopamine/Oxidopamine/*pharmacology

  • Source: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2012; Vol. 829, pp. 505-30.Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Striatal dopaminergic fiber recovery after acute L-DOPA treatment in 6-hydroxydopamine (6-OHDA) lesioned rats.

  • Authors : Fang C; Department of Neurology, Daping Hospital, Third Military Medical University, Chongqing 400042, China.; Yin J

Subjects: Oxidopamine*; Antiparkinson Agents/Antiparkinson Agents/Antiparkinson Agents/*pharmacology ; Dopamine/Dopamine/Dopamine/*metabolism

  • Source: Cell biochemistry and biophysics [Cell Biochem Biophys] 2011 Jan; Vol. 59 (1), pp. 49-56.Publisher: Humana Press Country of Publication: United States NLM ID: 9701934 Publication Model: Print Cited Medium:

Record details

×
  • 1-10 of  130 results for ""Oxidopamine""